Daclizumab Subcutaneous and Xenleta (Lefamulin Tablets)
Determining the interaction of Daclizumab Subcutaneous and Xenleta (Lefamulin Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: lefamulin
Brand name: Xenleta
Synonyms: Xenleta (Lefamulin Injection), Xenleta, Xenleta (oral/injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Xeomin
- Daclizumab Subcutaneous-Xerava
- Daclizumab Subcutaneous-Xerese
- Daclizumab Subcutaneous-Xerese Cream
- Daclizumab Subcutaneous-Xermelo
- Daclizumab Subcutaneous-Xgeva
- Xenleta (Lefamulin Tablets)-Dacogen
- Xenleta (Lefamulin Tablets)-Dacomitinib
- Xenleta (Lefamulin Tablets)-Dactinomycin
- Xenleta (Lefamulin Tablets)-Dactinomycin Injection
- Xenleta (Lefamulin Tablets)-Dactinomycin Intravenous
- Xenleta (Lefamulin Tablets)-Daklinza